© Globe Newswire
10.12.2025
LBRX
LISTED
NASDAQ
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
News Preview
NEW YORK, Dec. 10, 2025 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX) today announced that it has granted to Kaya Pai Panandiker, the new Chief Commercial Officer of LB Pharmaceuticals, an equity award outside of, but subject to the terms and conditions of, the LB Pharmaceuticals Inc 2025 Equity...
Themefolio
Profiler
Peergroup
© PR Newswire
10.12.2025
KEQU
LISTED
NASDAQ
Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2026
News Preview
STATESVILLE, N.C., Dec. 10, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its second quarter ended October 31, 2025.
Fiscal Year 2026 Second Quarter Results:Sales during the second qua...
Themefolio
Profiler
Peergroup
© PR Newswire
10.12.2025
NUVL
LISTED
NASDAQ
Nuvalent Appoints Ron Squarer to Board of Directors
News Preview
CAMBRIDGE, Mass., Dec. 10, 2025 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced the appointment of Ron Squarer to its Board of Directors....
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
10.12.2025
CRNX
LISTED
NASDAQ
Crinetics Pharmaceuticals Announces December 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
SAN DIEGO , Dec. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on December 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of 39,575 shares of its common stock and granted an aggregate of 26,525 restricted stock uni...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
10.12.2025
IMAB
LISTED
NASDAQ
NovaBridge Presents Positive Ragistomig Phase 1 Dose Expansion Data at ESMO-IO
News Preview
ROCKVILLE, Md., Dec. 10, 2025 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge or the Company) a global biotechnology platform company committed to accelerating access to innovative medicines, today announced the presentation of new data from the expanded 3mg/kg every 6 week (Q6W) Phase 1 dosing study for ragistomig, a bispeci...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.12.2025
AGE
LISTED
XASE
Serina Therapeutics Submits Complete Response to FDA Clinical Hold Letter for SER-252 Program
News Preview
– Company addresses FDA requests regarding formulation excipient – Global site start-up activities continue, with first-patient-in for registrational Phase 1b study targeted for Q1 2026, subject to FDA feedback...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.12.2025
BBOT
LISTED
NASDAQ
BBOT Announces Late-Breaking Preclinical Data on BBO-10203, a First-in-Class RAS:PI3Kα Breaker, at the San Antonio Breast Cancer Symposium (SABCS)
News Preview
SOUTH SAN FRANCISCO, Calif., Dec. 10, 2025 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced late-breaking preclinical data on BBO-10203, a first-in-class covalent small molecule RAS:PI3Kα breaker that selectively and s...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.12.2025
AARD
LISTED
NASDAQ
Aardvark Therapeutics Announces First Patient Dosed in Australia in HERO Phase 3 Trial for Prader-Willi Syndrome
News Preview
Multiple active sites and strong US enrollment continue to support Q3 2026 timing for topline data readout...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.12.2025
CRBP
LISTED
NASDAQ
Corbus Pharmaceuticals to Report Results from Phase 1a Study of Oral CB1 Inverse Agonist CRB-913 for the Treatment for Obesity on Thursday, December 11, 2025
News Preview
Company will host conference call and live webcast to review and discuss the data at 8:00 am ET Company will host conference call and live webcast to review and discuss the data at 8:00 am ET...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.12.2025
RYTM
LISTED
NASDAQ
Rhythm Pharmaceuticals to Announce Preliminary Data from Exploratory Phase 2 Trial Evaluating Setmelanotide in Prader-Willi Syndrome
News Preview
BOSTON, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that it will host a live conference call and webcast on Thursday, December 11 at 8:00 a.m. ET to disclose...
Themefolio
Profiler
Peergroup
© PR Newswire
10.12.2025
TLX
LISTED
ASX
Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration
News Preview
MELBOURNE, Australia and PALO ALTO, Calif., Dec. 11, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces a strategic clinical collaboration with Varian, a Siemens Healthineers company and global leader in radiation oncology, to develop novel clinical applications that combine Telix's theranostic prod...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.12.2025
MAIA
LISTED
XASE
MAIA Takes Aim at a $50B Immunotherapy Market with Breakthrough Telomere-Targeting Approach
News Preview
CHICAGO, Dec. 10, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology (NYSE American: MAIA) – The treatment paradigm for advanced non-small cell lung cancer (NSCLC) is undergoing another shift. After a decade of targeted therapies and checkpoint inhibitors (CPIs) dominating headlines, MAIA believes that a new therapeutic class—telomere-targeting agents—i...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
10.12.2025
AZTA
LISTED
NASDAQ
Azenta Authorizes $250 Million Share Repurchase Program
News Preview
BURLINGTON, Mass., Dec. 10, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that its Board of Directors has approved a share repurchase program under which the company may repurchase up to $250 million of its outstanding common stock. The Repurchase Program is intended to enhance shareholder value and capitalize on undervaluation....
Themefolio
Profiler
Peergroup
© ACCESSWIRE
10.12.2025
SKNY
LISTED
CSE
Lir Life Sciences Completes Design of a Comparative Animal Study Investigating Cell-Penetrating Peptide-Mediated Delivery of GLP/GIP-Based Obesity Therapies
News Preview
VANCOUVER, BC / ACCESS Newswire / December 10, 2025 / Lir Life Sciences Corp. (CSE:SKNY)(Frankfurt:N790, WKN: A41QA9) ("Lir" or the "Company") is pleased to announce the design of a new comparative cell-penetrating peptide-based uptake study (the "Study") of GLP/GIP[1]-based obesity therapies, further advancing its nov...
Themefolio
Profiler
Peergroup
© Newsfile
10.12.2025
HEM
LISTED
TSX
Hemostemix Inc. Announces FDA Pre-IND Meeting and NBPP of $960,000
News Preview
Calgary, Alberta--(Newsfile Corp. - December 10, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company"), the leading autologous (patient's own) stem cell therapy company offering VesCell™ (ACP-01) to individuals suffering from vascular dementia, angina, ischemic cardiomyopathy, congestive heart failure,...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.12.2025
EL
LISTED
EURONEXT
EssilorLuxottica joins forces with Fondazione Chips-IT to accelerate the future of smart eyewear
News Preview
EssilorLuxottica joins forces with Fondazione Chips-ITto accelerate the future of smart eyewear...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.12.2025
GNFT
LISTED
EURONEXT
GENFIT: GNS561 Shows Promising Antitumor Activity in Combination Therapy
News Preview
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), December 10, 2025 - GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today reports encouraging preliminary Phase 1b data from its CCA clinical trial evaluating GNS561 in comb...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.12.2025
EQS
LISTED
EURONEXT
EQUASENS ANNOUNCES ITS 2026 FINANCIAL CALENDAR
News Preview
Villers-lès-Nancy, December 10, 2026, 6:00 p.m. CET – Equasens (ISIN: FR 0012882389 – Ticker: EQS), a leader in digital solutions for healthcare professionals, announces its financial calendar for the 2026 financial year....
Themefolio
Profiler
Peergroup
© PR Newswire
10.12.2025
INNO
LISTED
CSE
Innocan Pharma Announces Public Filing of Amended Registration Statement for Proposed U.S. Public Offering
News Preview
HERZLIYA, Israel and CALGARY, AB, Dec. 10, 2025 /PRNewswire/ -- Innocan Pharma Corporation ("Innocan" or the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that, further to its press release of July 23, 2025, it has publicly filed an amendment to its registration statement on Form F-1 with the U.S. Securities and Exchange...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.12.2025
EAPI
LISTED
EURONEXT
Tristan Imbert co-opted as Independent Director
News Preview
Paris – December 10, 2025 - EUROAPI today announces that, following the resignation of Rodolfo Savitzky from his position as Independent Director (effective December 31, 2025)1, and upon the recommendation of the Nominations and Compensation Committee, the Board of Directors has decided to co-opt Tristan Imbert as Independent Director, subject to t...
Themefolio
Profiler
Peergroup
© PR Newswire
10.12.2025
INNO
LISTED
CSE
Innocan Pharma Announces Public Filing of Amended Registration Statement for Proposed U.S. Public Offering
News Preview
HERZLIYA, Israel and CALGARY, AB, Dec. 10, 2025 /CNW/ -- Innocan Pharma Corporation ("Innocan" or the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that, further to its press release of July 23, 2025, it has publicly filed an amendment to its registration statement on Form F-1 with the U.S. Securities and Exchange Commiss...
Themefolio
Profiler
Peergroup
© BusinessWire
10.12.2025
MLTX
LISTED
NASDAQ
MLTX Investor Deadline Alert: MoonLake (MLTX) Class Action Lawsuit – Hagens Berman Scrutinizing Nanobody Superiority Claims After 90% Plunge; December Lead Plaintiff Deadline Looms
News Preview
Global plaintiffs' rights firm Hagens Berman reminds investors that the Lead Plaintiff Deadline in the securities class action lawsuit against MoonLake Immunotherapeutics (NASDAQ: MLTX) is rapidly approaching: December 15, 2025.
The lawsuit alleges that MoonLake and certain executives made materially false and misleading statements regarding the...
Themefolio
Profiler
Peergroup
© PR Newswire
10.12.2025
AAWH.U
LISTED
CSE
Ascend Wellness Holdings Announces Partnership With Mister Jones in New Jersey
News Preview
Mister Jones Dispensary Set to Open December 19NEW YORK, Dec. 10, 2025 /CNW/ - Ascend Wellness Holdings, Inc. ("AWH," "Ascend," or the "Company") (CSE: AAWH.U/ OTCQX:AAWH), a multi-state, vertically integrated cannabis operator, has announced a partnership agreement with Mister Jones, LLC and longtime adult-use cannabis advocate Lerone Jones. This...
Themefolio
Profiler
Peergroup
© PR Newswire
10.12.2025
AAWH.U
LISTED
CSE
Ascend Wellness Holdings Announces Partnership With Mister Jones in New Jersey
News Preview
Mister Jones Dispensary Set to Open December 19NEW YORK, Dec. 10, 2025 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH," "Ascend," or the "Company") (CSE: AAWH.U/ OTCQX:AAWH), a multi-state, vertically integrated cannabis operator, has announced a partnership agreement with Mister Jones, LLC and longtime adult-use cannabis advocate Lerone Jone...
Themefolio
Profiler
Peergroup
© PR Newswire
10.12.2025
CI
LISTED
NYSE
The Cigna Group Foundation Awards an Additional $3 Million in Local Grants to Support Veterans' Mental Health
News Preview
New round of funding will strengthen community-driven efforts to address housing stability by repairing and adapting homes and providing mortgage and rental assistanceBLOOMFIELD, Conn., Dec. 10, 2025 /PRNewswire/ -- The Cigna Group Foundation, the philanthropic arm of The Cigna Group (NYSE: CI), today announced the 2025 grant recipients for its ve...
Themefolio
Profiler
Peergroup
© PR Newswire
10.12.2025
ANIX
LISTED
NASDAQ
Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025
News Preview
SAN JOSE, Calif., Dec. 10, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its Chairman and CEO, Dr. Amit Kumar, will participate in the upcoming Water Tower Research Fireside Chat Series taking place on Monday, D...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.12.2025
AONC
LISTED
OTC
American Oncology Network Welcomes Robert J. McDonald, MD, FACNM, as Radiology Medical Director and In-House Reading Radiologist
News Preview
American Oncology Network Welcomes Robert J. McDonald, MD, FACNM, as Radiology Medical Director and In-House Reading Radiologist...
Themefolio
Profiler
Peergroup
© BusinessWire
10.12.2025
OWLT
LISTED
NYSE
Owlet Launches Owlet360™ in the UK and Ireland, Bringing Data-Driven Reassurance to More Families
News Preview
Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announced the UK and Ireland launch of Owlet360™, a new subscription service designed to give parents a deeper, personalized understanding of their baby’s sleep and daily trends.
This press release features multimedia. View the full release here: htt...
Themefolio
Profiler
Peergroup
© BusinessWire
10.12.2025
ERF
LISTED
EURONEXT
The Eurofins Consumer Product Testing Network Completes Significant Laboratory Expansion in Vietnam
News Preview
Eurofins Consumer Product Testing Vietnam has completed a major expansion, seeing the laboratory move to a purpose-built 7,000 sq. m laboratory in Ho Chi Minh City. This new facility provides more than two and a half times the floor space of Eurofins Consumer Product Testing Vietnam’s previous site. This investment strengthens the Eurofins Consume...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.12.2025
OCGN
LISTED
NASDAQ
Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit
News Preview
MALVERN, Pa., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that Dr. Shankar Musunuri, Chairman, CEO, and Co-founder, will present at the Oppenheimer Movers in Rare Disease Summit taking place at the Sofitel New Yor...
Themefolio
Profiler
Peergroup
© BusinessWire
10.12.2025
PFE
LISTED
NYSE
TUKYSA Added to First-Line Maintenance Therapy Extends Median Progression-Free Survival by Over 8 Months in Patients with HER2+ Metastatic Breast Cancer
News Preview
Pfizer Inc. (NYSE: PFE) today announced detailed results from the Phase 3 HER2CLIMB-05 trial of the tyrosine kinase inhibitor TUKYSA® (tucatinib) as part of an investigational first-line maintenance treatment combination, following chemotherapy-based induction, in patients with human epidermal growth factor receptor 2-positive (HER2+) metastatic b...
Themefolio
Profiler
Peergroup
© PR Newswire
10.12.2025
PTCT
LISTED
NASDAQ
PTC Therapeutics Announces Health Canada Approval of Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU)
News Preview
- Broad label includes all age groups and full range of PKU subtypes -TORONTO, Dec. 10, 2025 /CNW/ - PTC Therapeutics Canada ULC announced that Health Canada has approved Sephience™ (sepiapterin) for the treatment of children and adults living with phenylketonuria (PKU). The approval includes broad labeling for the treatment of hyperphenylalaninem...
Themefolio
Profiler
Peergroup
© PR Newswire
10.12.2025
KZIA
LISTED
NASDAQ
Kazia Therapeutics Highlights New Clinical and Translational Findings Demonstrating Paxalisib's Ability to Reinvigorate Anti-Tumor Immunity Across Multiple Advanced Breast Cancer Populations including TNBC and HER2+
News Preview
First patient from TNBC trial demonstrated 76% tumor volume shrinkage with corresponding reductions in circulating tumor cells (CTC) and clustersReinvigoration of immune system + turning cold tumors hotPreliminary ex-vivo data in HER2+ patients demonstrates immune reinvigoration and reductions in CTC and clustersSYDNEY, Dec. 10, 2025 /PRNewswire/...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.12.2025
AIMI
LISTED
OTC
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
News Preview
Tom Equels, CEO of AIM ImmunoTech, discusses the unmet need and driving Ampligen forward in pancreatic cancer Tom Equels, CEO of AIM ImmunoTech, discusses the unmet need and driving Ampligen forward in pancreatic cancer...
Themefolio
Profiler
Peergroup
© Newsfile
10.12.2025
FEED
LISTED
NASDAQ
Envoy Medical Completes First Set of Activations in Final Stage of Pivotal Clinical Study for its First-Of-Its-Kind Fully Implanted Acclaim(R) Cochlear Implant
News Preview
Momentum continues to build for Company as series of clinical milestones are met, design choices cement differentiation from competition, and timeline comes into focusWhite Bear Lake, Minnesota--(Newsfile Corp. - December 10, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering full...
Themefolio
Profiler
Peergroup
© PR Newswire
10.12.2025
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLC
LEI: 5493003YBCY4W1IMJU04
NET ASSET VALUE
The estimated un-audited net asset val...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.12.2025
SMTI
LISTED
NASDAQ
Sanara MedTech Inc. and Biomimetic Innovations Provide Update on OsStic™
News Preview
Poised for U.S. market launch in Q1 2027 following the achievement of recent milestones and OsStic’s granted patent in 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
10.12.2025
HCTI
LISTED
NASDAQ
Healthcare Triangle, Inc. Signs Advance Agreement for the Acquisition of Next-Generation AI Customer Engagement Business, on track to generate $34M in Revenue for FY 2025
News Preview
PLEASANTON, Calif., Dec. 10, 2025 /CNW/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions for healthcare and life sciences, today announces that it has entered into an Advance Agreement with Teyame AI LLC, a St Kitts and Nevis corporation ("Teyame"), as part of its planned acquisiti...
Themefolio
Profiler
Peergroup
© PR Newswire
10.12.2025
HCTI
LISTED
NASDAQ
Healthcare Triangle, Inc. Signs Advance Agreement for the Acquisition of Next-Generation AI Customer Engagement Business, on track to generate $34M in Revenue for FY 2025
News Preview
PLEASANTON, Calif., Dec. 10, 2025 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions for healthcare and life sciences, today announces that it has entered into an Advance Agreement with Teyame AI LLC, a St Kitts and Nevis corporation ("Teyame"), as part of its planned ac...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.12.2025
MBRX
LISTED
NASDAQ
Moleculin Announces Exercise of Warrants for $6.8 Million Gross Proceeds
News Preview
HOUSTON, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today announced it has entered into agreements with certain holders of its existing warrants for the immediate...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.12.2025
VERU
LISTED
NASDAQ
Veru to Report Fiscal Year 2025 Financial Results on December 17th
News Preview
MIAMI, FL, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced it will host a conference call and audio webcast on Wednesday, December 17, 2025, at 8:00 a.m. ET to discu...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.12.2025
FBLG
LISTED
NASDAQ
FibroBiologics Files Patent Application Covering Novel Fibroblast-Based Chondrocyte Spheroid Platform for Orthopedic and Musculoskeletal Conditions
News Preview
Platform Poised to Expand into Joint and Cartilage Repair Platform Poised to Expand into Joint and Cartilage Repair...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.12.2025
MDMA
LISTED
CSE
PharmAla Biotech Completes Release Testing on Australian-Made LaNeo Capsules
News Preview
PharmAla completes delivery of a Phase 3 clinical trial contract after finishing release testing on an australian-made batch of LaNeo MDMA....
Themefolio
Profiler
Peergroup
© Globe Newswire
10.12.2025
LXRX
LISTED
NASDAQ
Lexicon Pharmaceuticals Announces Publication of Preclinical Data in the Journal of the Endocrine Society on Acyl-CoA Synthetase 5 (ACSL5) Reinforcing the Scientific Rationale for LX9851
News Preview
Lexicon Pharmaceuticals announces publication of preclinical data in the Journal of the Endocrine Society....
Themefolio
Profiler
Peergroup
© BusinessWire
10.12.2025
NEO
LISTED
NASDAQ
NeoGenomics to Present New ctDNA Research at SABCS 2025
News Preview
NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that data utilizing its RaDaR® 1.0 assay for the detection of molecular residual disease (MRD) will be presented at the 2025 San Antonio Breast Cancer Symposium (SABCS), taking place Dec. 9–12, 2025, at the Henry B....
Themefolio
Profiler
Peergroup
© BusinessWire
10.12.2025
STAA
LISTED
NASDAQ
Yunqi Capital Comments on STAAR Surgical’s Go-Shop Process and Alcon’s Revised Offer
News Preview
Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), today released the following letter to STAAR shareholders regarding the closing of STAAR’s go-shop period and the revised offer of Al...
Themefolio
Profiler
Peergroup
© PR Newswire
10.12.2025
CTSO
LISTED
NASDAQ
CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025
News Preview
PRINCETON, N.J., Dec. 10, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced that Dr. Phillip Chan, CEO, and Peter J. Mariani, CFO, will join Jason Kolbert, Head of Healthcare Research at D. B...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.12.2025
STEX
LISTED
NASDAQ
Streamex Corp. (NASDAQ: STEX) Joins Solana Policy Institute in the Project Open Coalition to Advance Regulated On-Chain Trading of Real-World Assets, Including GLDY
News Preview
LOS ANGELES, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Streamex Corp. (“Streamex” or the “Company”) (NASDAQ: STEX), a leader in institutional-grade tokenization of real-world assets, today announced it has joined Project Open, a landmark initiative working to establish a regulated framework for the issuance and trading of securities on public blockchain...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.12.2025
ABSI
LISTED
NASDAQ
Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research
News Preview
Partnership aims to destigmatize androgenetic alopecia and highlight the need for new therapeutic options that address the root cause of disease...
Themefolio
Profiler
Peergroup
© BusinessWire
10.12.2025
BRKR
LISTED
NASDAQ
Bruker Announces Orders for High-Performance Magnetic Resonance Systems for Materials and Life-Science Research from Leading European Institutions
News Preview
Bruker Corporation (Nasdaq: BRKR) today announced several significant European orders for high-performance magnetic resonance systems from three leading research institutions in France and Germany:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251210538867/en/AVANCE NEO 1 GHz system wi...
Themefolio
Profiler
Peergroup
© BusinessWire
10.12.2025
BEAT
LISTED
NASDAQ
HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment
News Preview
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Company’s groundbreaking 12-lead electrocardiogram (ECG) synthesis software for the assessment of arrhyt...
Themefolio
Profiler
Peergroup
© BusinessWire
10.12.2025
PLTR
LISTED
NASDAQ
U.S. Navy Partners with Palantir to Modernize Shipbuilding Supply Chain and Accelerate Shipbuilding
News Preview
The United States Navy announced a groundbreaking partnership with Palantir Technologies Inc. (NASDAQ: PLTR) to deploy Palantir’s Foundry and Artificial Intelligence Platform (AIP) across the nation’s Maritime Industrial Base (MIB). The initiative, ShipOS, authorizes up to $448 million to accelerate the adoption of artificial intelligence and auto...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.12.2025
MDNA
LISTED
TSX
Medicenna Updates MDNA11 Clinical Trial Results at the ESMO-IO Congress 2025, Further Bolstering its Anti-Tumor Activity in Advanced Solid Tumors
News Preview
MDNA11 demonstrates durable anti-tumor activity in phase-2 eligible expansion cohorts, enriched for immune checkpoint resistant melanoma, MSS endometrial cancer, MSI-H and TMB-H cancers, in each case exceeding objective response rate (ORR) benchmarks in these difficult to treat populations ...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.12.2025
BCT
LISTED
TSX
BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025
News Preview
PHILADELPHIA and VANCOUVER, British Columbia, Dec. 10, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, presents positive Phase 2 survival, and Phase 3 biomarker data across three...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.12.2025
KDEV
LISTED
STO
Karolinska Development's portfolio company Modus Therapeutics initiates dosing in phase 2a study in patients with chronic kidney disease with anemia
News Preview
STOCKHOLM, SWEDEN December 10, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company, Modus Therapeutics, has dosed the first patient in the phase 2a clinical study of sevuparin as a potential new treatment for chronic kidney disease with anemia. The study is conducted in Italy and will evaluate the saf...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.12.2025
SGMT
LISTED
NASDAQ
Sagimet’s License Partner Ascletis Announced Acceptance of New Drug Application for Denifanstat for the Treatment of Moderate to Severe Acne by China’s National Medical Products Administration
News Preview
SAN MATEO, Calif., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that Ascletis Pharma Inc. issued a December 10 statement that China’s National Medical Products Administrati...
Themefolio
Profiler
Peergroup
© PR Newswire
10.12.2025
IDYA
LISTED
NASDAQ
IDEAYA Biosciences Announces IND Submission for IDE574, a Potential First-In-Class KAT6/7 Dual Inhibitor for Breast and Lung Cancers
News Preview
Phase 1 dose escalation trial of monotherapy IDE574 expected to begin in 1Q 2026Targeting to present preclinical data detailing pharmacologic profile and evidence of anti-tumor activity in solid tumor models at a medical conference in 1H 2026SOUTH SAN FRANCISCO, Calif., Dec. 10, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a leadi...
Themefolio
Profiler
Peergroup
© PR Newswire
10.12.2025
WST
LISTED
NYSE
West Declares Quarterly Dividend
News Preview
EXTON, Pa., Dec. 10, 2025 /PRNewswire/ -- On December 9, 2025, the board of directors of West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, declared its regular quarterly dividend of $0.22 per share on the Company's common stock. The dividend is payable on February 4, 2026, t...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.12.2025
MDWD
LISTED
NASDAQ
MediWound Reports New Clinical Data Demonstrating NexoBrid®’s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries
News Preview
MediWound Reports New Clinical Data Demonstrating NexoBrid®’s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.12.2025
TLX
LISTED
ASX
Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration
News Preview
MELBOURNE, Australia and PALO ALTO, Calif., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces a strategic clinical collaboration with Varian, a Siemens Healthineers company and global leader in radiation oncology, to develop novel clinical applications that combine Telix’s theranostic...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
